Analystreport

Oncolytics Biotech, Inc. (NASDAQ: ONCY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating.

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com